v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
In-process research and development $ 10,000 $ 10,000
Research and development 24,738 11,838
General and administrative 27,221 44,210
Restructuring and impairment charges 16,622 7,493
Total operating expenses 78,581 73,541
Loss from operations (78,581) (73,541)
Interest income 3,858 6,987
Interest expense (5,829) (8,992)
Other rental income 8,968 4,267
Other income (expense), net 212 (2,856)
Net loss (71,372) (74,135)
Other comprehensive income:    
Foreign currency translation (342) 168
Unrealized loss on available-for-sale securities, net (13) (48)
Net comprehensive loss $ (71,727) $ (74,015)
Net loss per share, basic (in dollars per share) $ (10.70) $ (11.39)
Net loss per share, diluted (in dollars per share) $ (10.70) $ (11.39)
Weighted-average shares used in computing net loss per share, basic (in shares) 6,668,268 6,510,138
Weighted-average shares used in computing net loss per share, diluted (in shares) 6,668,268 6,510,138